Literature DB >> 32325183

Role of chemokines, innate and adaptive immunity.

Kurt A Zimmerman1, Katharina Hopp2, Michal Mrug3.   

Abstract

Polycystic Kidney Disease (PKD) triggers a robust immune system response including changes in both innate and adaptive immunity. These changes involve immune cells (e.g., macrophages and T cells) as well as cytokines and chemokines (e.g., MCP-1) that regulate the production, differentiation, homing, and various functions of these cells. This review is focused on the role of the immune system and its associated factors in the pathogenesis of PKDs as evidenced by data from cell-based systems, animal models, and PKD patients. It also highlights relevant pre-clinical and clinical studies that point to specific immune system components as promising candidates for the development of prognostic biomarkers and therapeutic strategies to improve PKD outcomes. Published by Elsevier Inc.

Entities:  

Keywords:  ADPKD; ARPKD; Autosomal dominant polycystic kidney disease; Autosomal recessive polycystic kidney disease; Chemokines, Macrophages; Immune response; Kidney function; T cells

Year:  2020        PMID: 32325183      PMCID: PMC8063685          DOI: 10.1016/j.cellsig.2020.109647

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  188 in total

Review 1.  Cell signals transduced by complement.

Authors:  Osnat Bohana-Kashtan; Lea Ziporen; Natalie Donin; Sarah Kraus; Zvi Fishelson
Journal:  Mol Immunol       Date:  2004-07       Impact factor: 4.407

2.  MCP-1 gene activation marks acute kidney injury.

Authors:  Raj Munshi; Ali Johnson; Edward D Siew; T Alp Ikizler; Lorraine B Ware; Mark M Wurfel; Jonathan Himmelfarb; Richard A Zager
Journal:  J Am Soc Nephrol       Date:  2010-11-11       Impact factor: 10.121

Review 3.  Role of immunocompetent cells in nonimmune renal diseases.

Authors:  B Rodríguez-Iturbe; H Pons; J Herrera-Acosta; R J Johnson
Journal:  Kidney Int       Date:  2001-05       Impact factor: 10.612

4.  The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.

Authors:  Christopher J Ward; Marie C Hogan; Sandro Rossetti; Denise Walker; Tam Sneddon; Xiaofang Wang; Vicky Kubly; Julie M Cunningham; Robert Bacallao; Masahiko Ishibashi; Dawn S Milliner; Vicente E Torres; Peter C Harris
Journal:  Nat Genet       Date:  2002-02-04       Impact factor: 38.330

5.  Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.

Authors:  Li Chen; Xia Zhou; Lucy X Fan; Ying Yao; Katherine I Swenson-Fields; Mihaela Gadjeva; Darren P Wallace; Dorien J M Peters; Alan Yu; Jared J Grantham; Xiaogang Li
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

6.  Polycystic kidney disease in bull terriers: an autosomal dominant inherited disorder.

Authors:  C A O'Leary; B M Mackay; R Malik; J E Edmondston; W F Robinson; C R Huxtable
Journal:  Aust Vet J       Date:  1999-06       Impact factor: 1.281

7.  Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

Authors:  Claudio G Brunstein; Jeffrey S Miller; Qing Cao; David H McKenna; Keli L Hippen; Julie Curtsinger; Todd Defor; Bruce L Levine; Carl H June; Pablo Rubinstein; Philip B McGlave; Bruce R Blazar; John E Wagner
Journal:  Blood       Date:  2010-10-15       Impact factor: 22.113

Review 8.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

9.  Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations.

Authors:  Shuei Liong Lin; Ana P Castaño; Brian T Nowlin; Mark L Lupher; Jeremy S Duffield
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

10.  TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes.

Authors:  Riccardo Magistroni; Alessandra Mangolini; Sonia Guzzo; Francesca Testa; Mario R Rapanà; Renzo Mignani; Giorgia Russo; Francesco di Virgilio; Gianluca Aguiari
Journal:  BMC Nephrol       Date:  2019-09-13       Impact factor: 2.388

View more
  9 in total

Review 1.  Molecular Mechanisms of Epigenetic Regulation, Inflammation, and Cell Death in ADPKD.

Authors:  Ewud Agborbesong; Linda Xiaoyan Li; Lu Li; Xiaogang Li
Journal:  Front Mol Biosci       Date:  2022-06-29

2.  Renal plasticity revealed through reversal of polycystic kidney disease in mice.

Authors:  Ke Dong; Chao Zhang; Xin Tian; Daniel Coman; Fahmeed Hyder; Ming Ma; Stefan Somlo
Journal:  Nat Genet       Date:  2021-10-11       Impact factor: 41.307

Review 3.  Cytopenia in autosomal dominant polycystic kidney disease (ADPKD): merely an association or a disease-related feature with prognostic implications?

Authors:  Pieter Schellekens; Willem Roosens; Bert Bammens; Djalila Mekahli; Isabelle Meyts; Rudi Vennekens
Journal:  Pediatr Nephrol       Date:  2021-01-27       Impact factor: 3.714

Review 4.  Resident Macrophages in Cystic Kidney Disease.

Authors:  Zhang Li; Kurt A Zimmerman; Bradley K Yoder
Journal:  Kidney360       Date:  2021-01-28

5.  A Comprehensive Immune Cell Atlas of Cystic Kidney Disease Reveals the Involvement of Adaptive Immune Cells in Injury-Mediated Cyst Progression in Mice.

Authors:  Cheng J Song; Zhang Li; Ummey Khalecha Bintha Ahmed; Sarah J Bland; Alex Yashchenko; Shanrun Liu; Ernald J Aloria; Jeremie M Lever; Nancy M Gonzalez; Marisa A Bickel; Cory B Giles; Constantin Georgescu; Jonathan D Wren; Mark L Lang; Etty N Benveniste; Laurie E Harrington; Leo Tsiokas; James F George; Kenneth L Jones; David K Crossman; Anupam Agarwal; Michal Mrug; Bradley K Yoder; Katharina Hopp; Kurt A Zimmerman
Journal:  J Am Soc Nephrol       Date:  2022-02-02       Impact factor: 14.978

Review 6.  Insights Into the Molecular Mechanisms of Polycystic Kidney Diseases.

Authors:  Valeriia Y Vasileva; Regina F Sultanova; Anastasia V Sudarikova; Daria V Ilatovskaya
Journal:  Front Physiol       Date:  2021-09-08       Impact factor: 4.566

7.  Circulating Vitreous microRNA as Possible Biomarker in High Myopic Eyes with Macular Hole.

Authors:  Yoshimasa Ando; Hiroshi Keino; Makoto Inoue; Kazunari Hirota; Hiroyuki Takahashi; Kimihiko Sano; Takashi Koto; Tomohito Sato; Masaru Takeuchi; Akito Hirakata
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

8.  A Teleost CXCL10 Is Both an Immunoregulator and an Antimicrobial.

Authors:  Huili Li; Yuanyuan Sun; Li Sun
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

Review 9.  Shared pathobiology identifies AMPK as a therapeutic target for obesity and autosomal dominant polycystic kidney disease.

Authors:  Ioan-Andrei Iliuta; Xuewen Song; Lauren Pickel; Amirreza Haghighi; Ravi Retnakaran; James Scholey; Hoon-Ki Sung; Gregory R Steinberg; York Pei
Journal:  Front Mol Biosci       Date:  2022-08-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.